The pitfalls of direct oral anticoagulants
Автор: Gitelson D.G., Vasiliev A.E., Danishian K.I., Zozulya N.I., Abugov S.A.
Журнал: Вестник Национального медико-хирургического центра им. Н.И. Пирогова @vestnik-pirogov-center
Рубрика: Обзоры литературы
Статья в выпуске: 3, 2025 года.
Бесплатный доступ
Anticoagulant drugs have undergone drastic changes in recent decades. The introduction of direct oral anticoagulants into clinical practice has led to their widespread use for long-term oral anticoagulant therapy. There is less control over therapy, and medications are prescribed by doctors of many specialties. This monitoring system for patients receiving direct oral anticoagulants is suboptimal. And the lack of antidotes for apixaban and rivaroxaban exacerbate the problem.
Direct oral anticoagulants, apixaban, rivaroxaban, dabigatran
Короткий адрес: https://sciup.org/140310629
IDR: 140310629 | DOI: 10.25881/20728255_2025_20_3_126